Read insightful recaps of Biointron’s conferences, lunch and learns, and antibody-related events. Stay updated on key takeaways and highlights from the latest gatherings.
The 17th Annual World ADC San Diego Summit highlighted novel payload mechanisms, antibody engineering, bispecific and dual-payload ADCs, and clinical translation. Emerging strategies to improve therapeutic efficacy, overcome treatment resistance, and expand therapeutic windows were also discussed.
Recap of Antibodies After Hours Boston 2026: IPI's DELPHI developability prediction, CDR H3 polyreactivity insights, and Biointron's RushDATA™ wet-lab platform.
Key trends from the 17th World Bispecific Summit 2026 in Boston: AI-guided design, CD2/CD28 T-cell engagers, conditional antibodies, multispecific ADCs.
Biointron’s Antibodies After Hours: From Algorithms to Antibodies was held at The Hangar in South San Francisco, on Friday, September 4, 2026. “Antibodies After Hours” is a networking reception series from Biointron held in biotech hubs across the United States, with events previously hosted in S
ADLM 2026 had discussions across clinical chemistry, diagnostic immunology, microbiology, cancer diagnostics, cardiovascular disease, point-of-care testing, automation, data science, and other areas of laboratory medicine.
Learn how RushData supports antibody screening with structured experimental data, with highlights from Biointron’s BIO 2026 reception in San Diego.
Two popular topics discussed at the 2026 BIO International Convention were developments in antibody-drug conjugates (ADCs) and AI in biology. Held on June 22-25 in San Diego, California, read on for a quick recap.
Research recap on Antibody Engineering & Therapeutics Europe 2026. Antibody innovation is clearly advancing towards engineered, data-driven, and conditionally active therapeutics.
Read for a recap of trends in PEGS 2026. The event brought together industry leaders from the pharmaceutical and biotech sectors to discuss protein and antibody engineering, drug development, immunotherapy, radiotherapy, and AI/ ML-driven biologics research.
The 2026 ChAbS Annual Conference, “10 Years Together: Forging the Future of Antibody Therapeutics,” was held on May 9-10, 2026, in Cambridge, MA.
Biointron’s 2026 Lunch & Learn was held at CIC Cambridge, MA on May 8, 2026. The session featured two guest speakers: Shashi Jatiani, PhD, Director of Strategic Partnerships at SeromYx Systems, and Lee Andrews, Associate Director of Bioanalytical Development at Visterra.
BIO Korea 2026 was held on Aprill 28-30, 2026, bringing together academic scholars and experts in the biopharma and healthcare industry to share the latest technology trends and engage in discussion.